02May 2023
Plantis Licenses Two of Canonic’s Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market
20February 2023
Canonic Successfully Launched Six Second-Generation Cannabis Products with Higher THC and Rich Terpene Profiles
21September 2022
Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles
12September 2022
Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida
16February 2022
Canonic Announces Professor Itamar Grotto Joining its Board of Directors
31January 2022
Canonic Announces Shipment of its Cannabis Varieties to Europe
18January 2022
Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis
19October 2021
Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in Israel
31August 2021
Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel
25March 2021
Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel
24February 2021
Cannbit, subsidiary of Tikun Olam-Cannbit, and Canonic of Evogene group announce collaboration for the development of novel medical cannabis products
23December 2020
Canonic Announces Signing of First Cultivation Agreement for its Medical Cannabis Varieties
11November 2020
Canonic Received Approval for Propagation of Medical Cannabis from the Israel Medical Cannabis Agency
